{
  "info": {
    "company_name": "aTyr Pharma Inc",
    "company_url": "https://www.responsibilityreports.com/Company/atyr-pharma-inc",
    "ticker_name": "LIFE",
    "exchange": "NASDAQ",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "about_company": "aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for\u2026More",
    "num_employees": "51-200 Employees",
    "location": "Based in San Diego, California"
  },
  "reports": []
}